WorthPointe’s HCA Healthcare HCA Stock Holding History

WorthPointe’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-489	Closed	-$231K	–	125
2026 Q1	$231K	Sell	489 -6	-1%	-$3.02K	0.06%	108
2025 Q4	$231K	Sell	495 -35	-7%	-$16.3K	0.06%	124
2025 Q3	$226K	Hold	530	–	–	0.08%	97
2025 Q2	$203K	Buy	+530	New	+$191K	0.09%	95
2024 Q4	–	Sell	-529	Closed	-$215K	–	95
2024 Q3	$215K	Buy	+529	New	+$194K	0.09%	72

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

WorthPointe's HCA Position: Q2 2026 in Review

WorthPointe sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 489 shares — an estimated $231K sold.

WorthPointe first reported a position in HCA in Q3 2024 and held it in 5 quarters. The position peaked at $231K in Q1 2026. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

WorthPointe reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
WorthPointe sold 489 HCA Healthcare shares in Q2 2026, an estimated $231K.
WorthPointe first reported a position in HCA Healthcare in Q3 2024 and held it in 5 quarters.
WorthPointe's HCA Healthcare position peaked at $231K in Q1 2026.
1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on WorthPointe's 13F filing for Q2 2026, filed 31 Jul 2026.